Document Detail


Hedgehog signaling in glioblastoma multiforme.
MedLine Citation:
PMID:  22406999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Glioblastoma multiforme (GBM) is the most malignant brain tumor in adults with a median survival of 14.6 mo under the best available treatment. New treatment strategies are therefore urgently required, for which a profound understanding of tumor biology is necessary. Much effort has been devoted to tumor-specific aberrant signaling processes. Recently it was discovered that the transcription factor Gli1, which is activated by hedgehog signaling, is a highly predictive marker in GBM, as determined by immunohistochemistry. To determine whether GBM cells have transcriptionally active Gli1, we performed experiments with reporter genes with cells isolated from surgically removed human tumors and cell lines. We also determined whether the hedgehog signaling inhibitor cyclopamine influences reporter gene expression and cell viability, and we determined the expression of Gli1, SHH and Patched1 by quantitative real-time RT-PCR. Reporter gene analysis of nine cultures and four cell lines demonstrated a significantly enhanced transcriptional activity in six tumor cell cultures and all cell lines. Analysis of cell viability in the presence of cyclopamine revealed a response of all cell cultures with the exception of one primary culture and one cell line, but only one cell line responded to cyclopamine with reduced hedgehog signaling activity. This indicates that the toxicity of cyclopamine toward GBM cells is independent from hedgehog signaling. Since no correlation between hedgehog activity and SHH, Gli1 and Patched1 mRNA levels was observed we conclude that other mechanisms aside from transcriptional regulation of these factors are responsible for hedgehog activity in tumor cells derived from GBM.
Authors:
Stefanie Braun; Henry Oppermann; Antje Mueller; Christof Renner; Amalya Hovhannisyan; Rainer Baran-Schmidt; Rolf Gebhardt; Alan Hipkiss; Joachim Thiery; Jürgen Meixensberger; Frank Gaunitz
Related Documents :
23179339 - Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteaso...
23335999 - Assessment of tracer (99m)tc(v)-dmsa uptake as a measure of tumor cell proliferation in...
23430509 - Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell li...
9204259 - T-cell-dependent pathways in rheumatoid arthritis.
23287709 - In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using hk-2 human...
23369649 - Satellite cell therapy - from mice to men.
22760929 - Short- and long-term toxicities of multi-walled carbon nanotubes in vivo and in vitro.
10366429 - A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by cu...
9256159 - Characterization of a chinese hamster ovary cell line with acquired resistance to the b...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-05-01
Journal Detail:
Title:  Cancer biology & therapy     Volume:  13     ISSN:  1555-8576     ISO Abbreviation:  Cancer Biol. Ther.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-07-19     Completed Date:  2012-12-14     Revised Date:  2013-02-05    
Medline Journal Info:
Nlm Unique ID:  101137842     Medline TA:  Cancer Biol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  487-95     Citation Subset:  IM    
Affiliation:
Klinik und Poliklinik für Neurochirurgie, Universitätsklinikum Leipzig AöR, Leipzig, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Line, Tumor
Cell Survival / drug effects
Gene Expression Regulation, Neoplastic
Genes, Reporter
Glioblastoma / metabolism*
Hedgehog Proteins / metabolism*
Humans
Oncogene Proteins / genetics,  metabolism
Receptors, Cell Surface / genetics
Signal Transduction*
Trans-Activators / genetics,  metabolism
Transcription, Genetic
Transfection
Veratrum Alkaloids / pharmacology
Chemical
Reg. No./Substance:
0/Gli protein; 0/Hedgehog Proteins; 0/Oncogene Proteins; 0/Receptors, Cell Surface; 0/Trans-Activators; 0/Veratrum Alkaloids; 0/patched receptors; ZH658AJ192/cyclopamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor...
Next Document:  Investigation on synthesis and properties of isosorbide based bis-GMA analogue.